These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa. Maningi NE, Malinga LA, Antiabong JF, Lekalakala RM, Mbelle NM. BMC Infect Dis; 2017 Dec 28; 17(1):795. PubMed ID: 29282012 [Abstract] [Full Text] [Related]
25. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens. Kostera J, Leckie G, Tang N, Lampinen J, Szostak M, Abravaya K, Wang H. Tuberculosis (Edinb); 2016 Dec 28; 101():137-143. PubMed ID: 27865383 [Abstract] [Full Text] [Related]
26. Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR-TB test. Ramasubban G, Michael JS, Gupta R, Venkatesan M, Beauton AP, Hoffner S, Asalapuram P. Int J Mycobacteriol; 2024 Jan 01; 13(1):91-95. PubMed ID: 38771285 [Abstract] [Full Text] [Related]
30. Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis. Pérez-García F, Ruiz-Serrano MJ, López Roa P, Acosta F, Pérez-Lago L, García-De-Viedma D, Bouza E. J Microbiol Methods; 2017 Aug 01; 139():74-78. PubMed ID: 28511895 [Abstract] [Full Text] [Related]
32. Evaluation of a membrane hybridization array for detection of Mycobacterium tuberculosis complex and resistance to isoniazid and rifampin in sputum specimens, mycobacterial liquid cultures, and clinical isolates. Chen CJ, Yang YC, Huang HH, Chang TC, Lu PL. Kaohsiung J Med Sci; 2019 Oct 01; 35(10):615-623. PubMed ID: 31433118 [Abstract] [Full Text] [Related]
34. Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis. Hofmann-Thiel S, Molodtsov N, Duffner C, Kadyrov A, Kalmambetova G, Kabirov O, Rajabov A, Parpieva N, Sayfutdinov Z, Vogel M, Vogel H, Antonenka U, Hoffmann H. Int J Tuberc Lung Dis; 2019 Apr 01; 23(4):458-464. PubMed ID: 31064625 [Abstract] [Full Text] [Related]
36. Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China. Chen C, Kong W, Zhu L, Zhou Y, Peng H, Shao Y, Song H, Liu Q, Li G, Shi J, Zhong C, Zhu L, Ding X, Yu H, Yang H, Lu W. Int J Tuberc Lung Dis; 2014 Sep 01; 18(9):1034-9. PubMed ID: 25189549 [Abstract] [Full Text] [Related]
38. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. Huang WL, Chen HY, Kuo YM, Jou R. J Clin Microbiol; 2009 Aug 01; 47(8):2520-4. PubMed ID: 19494067 [Abstract] [Full Text] [Related]
40. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India. Ahmed S, Shukla I, Fatima N, Varshney SK, Shameem M, Tayyaba U. Int J Mycobacteriol; 2018 Aug 01; 7(4):315-327. PubMed ID: 30531028 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]